Introduction
Rapid tissue generation is exhibited in embryonic development and wound healing. Increased production of hyaluronic acid (HA)' is an early event in connective tissue reparative glycylglycine/0. 14 M NaCl at pH 7.2; HA, hyaluronic acid; PSH, penicillin (100 U/ml), streptomycin 100 ,g/ml, and Hepes buffer; TIMP, tissue inhibitor of metalloproteinase.
The Journal of Clinical Investigation, Inc. Volume 83, February 1989, 629-636 processes associated with wound healing in mammals and limb regeneration in amphibians (1) (2) (3) (4) . During embryonic development, cellular migration has been correlated with elevations of HA concentrations in chick cornea and mouse neural crest (4) (5) (6) .
HA is synthesized early during the course of an inflammatory reaction and is later degraded by fibroblasts during the healing phase of inflammation at a time when synthesis of sulfated glycosaminoglycans (GAGs) is increasing (7) . Mechanisms involved in controlling this resynthesis ofGAGs are not completely understood. In the present report, we have observed that natural human IL-1:, human recombinant (hr) IL-la and f3 and synthetic human IL-I#3 peptide 163-171 stimulate the synthesis of HA by dermal fibroblasts in vitro. The potential importance of the observation in postinflammatory tissue repair is discussed.
Methods
Fibroblast cultures. Cultures of human fibroblasts were established from infant foreskin explants as previously described in maintenance medium consisting of Eagle's minimum essential medium (MEM) supplemented with nonessential amino acids, ascorbic acid (50 ,g/ml), NaHCO3 and Hepes buffers (pH 7.2), penicillin (100 U/ml), streptomycin (100 0g/ml), amphotericin B (1 ztg/ml), and 9% heat-inactivated FCS (8) .
Leukocyte cultures. Mononuclear leukocytes (MNL), separated by the Ficoll-Hypaque technique from venous blood of normal donors were cultured at a density of 3 X 106 cells/ml ofserum-free RPMI 1640 medium supplemented with penicillin (100 U/ml), streptomycin (100 Ag/ml), and Hepes buffer (PSH) (Gibco Laboratories, Grand Island, NY) for 72 h (9) . Cultures were stimulated with PHA, 1 gg/ml (Burroughs Wellcome, Research Triangle Park, NC). Culture supernatants were stored at -70'C for up to 3 wk until they were tested for their ability to stimulate fibroblast GAG production.
Enzymatic analysis ofGAGs. Enzymatic analysis of the species of GAGs produced by fibroblasts was performed as previously described (1) . The GAGs were labeled by incubating confluent fibroblasts (35 mm petri dishes) with 25 ,Ci/ml [3H]acetate (sp act 3.4 Ci/mmol; New England Nuclear, Boston, MA) and 10% (by volume) test sample for 24 h. After pronase digestion, each sample was divided into eight aliquots (0.5 ml each), suspended in enriched Tris buffer (0.05 M Tris, 0.03 M sodium acetate, 0.04 M NaCl, and 100 ug/liter BSA, at pH 7.2), and incubated at 37°C overnight with either buffer alone, Streptomyces hyaluronidase (100 TRU/ml; Calbiochem-Behring Corp., La Jolla, CA), an enzyme that degrades only HA; chondroitinase AC II (3.1 U/ml), an enzyme that degrades both HA and CS; or with chondroitinase ABC (2 U/ml), an enzyme that degrades HA, CS, and DS (1, 10, 11). The chondroitinase enzymes were obtained from Miles Laboratories, Elkhart, IN. After incubation, the samples were boiled to inactivate the enzymes, and carrier GAG (250 ,g HA, and 250 ,g CS) was added. The undigested GAGs were then precipitated with 5 mg cetyl trimethylammonium bromide (CTAB), washed with enriched Tris buffer, solubilized, and counted. Subtraction ofthe labeled GAGs resistant to Streptomyces hyaluronidase from total CTAB-precipitable radioactivity determined the radioactivity in HA. Subtraction of labeled GAG resistant to chondroitinase AC II from the Streptomyces hyaluronidase resistant counts determined the radioactivity in CS. Similarly, the fraction of radioactivity found in the DS fraction was determined by subtracting chondroitinase ABC resistant labeled GAG from chondroitinase AC-resistant labeled GAG (1) .
HA production assay. Initial studies indicated HA levels were higher in the medium than in fibroblast cell layers after IL-l stimulation. In light of these data and to facilitate analysis of large numbers of samples, cells were routinely cultured in Falcon 3008 24 well plates, and only the fibroblast culture supernatants were assayed for HA. After 72 h culture, medium was removed from each well, replaced with 400
Ml of maintenance medium containing 2.5% FCS, and cultures were incubated for an additional 24 h. Medium was then removed from each well and was replaced with 400 Ml maintenance medium supplemented with 2.5% FCS and 25 ACi/ml [3HJacetate. Control or test samples (100-MI aliquots) were then added to appropriate wells, and fibroblasts were cultured for an additional 24 h. Column fractions were tested in duplicate. All other samples were tested in triplicate.
Fibroblast culture supernatants from duplicate or triplicate wells were harvested, pooled, boiled to inactivate endogenous endoglycosidases, and incubated for 16 h (560C) with protease (1 mg/ml). The reaction was stopped by boiling for 3 min. Samples were dialyzed extensively at 4VC against 0. Analysis of unsaturated disaccharides. GAGs were isolated from fibroblast culture supernatants as previously described ( 12) , identified, and quantitated by isolation of the unsaturated disaccharide degradation products resulting from chondroitinase ABC digestion. incubation, the supernatants were harvested. The cell layers, after being washed three times with PBS, were trypsinized, harvested, and pelleted by centrifugation. The cells from each well were resuspended in 400 Ml maintenance medium. The cell suspensions and harvested supernatants were incubated with protease (1 mg/ml) at 560C for 5 h and dialyzed against water to remove digested radioactivity. HA levels were then quantitated by the hyaluronic acid production assay described above.
Conventional molecular sieve chromatography. Columns 1.5 cm in diameter and 100 cm in length containing Sephadex G-200 or G-100 were used to fractionate supernatants from cultures of MNL stimulated by PHA as previously described (8) .
Thymocyte proliferation assays. IL-l activity was quantitated by measuring the uptake of tritiated thymidine ([3H]TdR) by thymocytes in direct mitogenic or comitogenic assays as previously described (14, 15) .
Recombinant IL-la and /3. Purified human recombinant (hr) IL-l a and / were purchased from Genzyme Corp. (Boston, MA). These preparations each contained 45.5 thymocyte-stimulating units/ng of IL-1. HrIL-la and /3 correspond to the pI 5 and pI 7 forms of IL-1, respectively, and have been previously described in detail by March and co-workers (16).
Isolation ofnatural IL-l/3. Natural IL-1/3 (pI 7.0) was isolated from supernatants of cultures of monoblasts from a patient with monocytic leukemia as previously described (17) . Briefly, harvested supernatants containing IL-l were subjected to diafiltration, ultrafiltration and isoelectric focusing (IEF). Fractions generated by isoelectric focusing in Anti-hrIL-Ja and 3 antibodies. Purified rabbit anti-hrIL-la and anti-hrIL-l/ immunoglobulin were obtained from Genzyme. These antibody reagents were raised against purified hrIL-1 a and /3 and neutralize the biological activity of hrIL-I a and /3, respectively. They have highly specific immunological reactivity with human IL-la and /, respectively, but do not bind to IL-2, IL-3, IL-4, colony stimulating factor, interferon y or tumor necrosis factor.
High performance liquid chromatography. Natural IL-1,B isolated by IEF was subjected to analytical HPLC. Molecular sieve chromatography was performed using two TSK 125 protein analysis columns (Bio-Rad) connected in tandem. The columns were equilibrated and were run with GGBS.
DNA quantitation. DNA content of fibroblast monolayers was measured by the method of Kissane and Robins (18) . Measurement ofPGE2. PGE2 was extracted from fibroblast culture supernatants and measured by a previously described radioimmunoassay technique (19) .
Synthesis ofhuman IL-1/3 Peptide 163-171. The nonapeptide, ValGln-Gly-Glu-Glu-Ser-Asn-Asp-Lys, representing residues 163-171 of the deduced human IL-IO sequence (16) and an unrelated decapeptide Leu-Ala-Glu-Leu-Tyr-Val-Arg-Glu-His-Leu were synthesized by the solid-phase method of Merrifield with the aid of a Beckman (model 990) automated peptide synthesizer (20) . The peptides were purified by gel filtration and reverse phase HPLC (21) . The amino acid composition of the peptides was determined by use of a Beckman 121 MB automatic amino acid analyzer (22) . The amino acid sequence was confirmed by automatic Edman degradation using a Beckman 890 M System (23).
Results
Stimulation offibroblast HA production by natural IL-I. Partially purified (dialfiltration, ultrafiltration, and IEF) natural IL-1/3 from monocytic leukemia cells stimulated HA production and thymocyte proliferation by fibroblasts in a dose-dependent manner (Fig. 1 preparation was fractionated by analytical gel filtration-HPLC, and column fractions were tested for their ability to stimulate fibroblast HA production and thymocyte proliferation (Fig. 2) . The two biologic activities coeluted from the tandem TSK 125 columns, further suggesting that the factor stimulating HA production by fibroblasts was IL-1 (Fig. 2) .
Additional studies were performed to further characterize the effect of IL-1 on HA and other GAG synthesis by fibroblasts. Since such experiments required large amounts of IL-1, we used supernatants from cultures of PHA-stimulated MNL and partially purified MNL or monocytic leukemia cell-derived IL-1 in these studies. Two lines ofevidence indicated that most ofthe HA stimulating activity in supernatants from PHA stimulated MNL cultures could be attributed to IL-1. In pre- . Natural human IL-1/3 prepared as described in Fig. 1 was fractionated by gel filtration-HPLC on a TSK 125 protein analysis column and fractions were tested for their ability to stimulate thymocyte proliferation and fibroblast HA production. liminary studies, we found that the HA-and murine thymocyte-stimulating activities consistently eluted in the same fractions from conventional gel filtration columns, or gel filtration-and ion exchange-HPLC columns (data not shown). In addition, -81 to 54% of the HA stimulating activity in supernatants from cultures of PHA-stimulated MNL was blocked by polyclonal antibodies to hrIL-la and /3 (Table I) . While these data suggest that IL-1 is the major HA-stimulatory factor produced by PHA-stimulated MNL, they do not exclude the possibility that other factors or cytokines produced by PHA-stimulated MNL may potentiate IL-1 effects on HA production by fibroblasts.
Since the incorporation of [3H]acetate, used in the assay to measure HA production by fibroblasts could theoretically be influenced by the rate of acetate transport and by fluctuations in precursor pool size, GAGs were also measured by the amounts of unsaturated disaccharides released after treatment of supernatants from fibroblast cultures with chondroitinase ABC (Table II) . In three consecutive experiments, we found that supernatant from cultures of peripheral blood MNL stimulated previously by PHA consistently caused a significant increase in A-Di-OS levels when added to confluent fibroblast cultures for 72 h (Table II) . Levels of A-Di-4S and A-Di-6S were also significantly increased, although to a lesser degree, after stimulation of fibroblasts with the PHA-MNL supernatant in two of three and one of three experiments, respectively (Table II) . This suggests that IL-1 stimulated production predominantly of HA rather than of other GAGs. The increase in GAG production could not be attributed to a stimulation of fibroblast growth since fibroblast numbers in the cell monolayers of control and experimental dishes were not statistically different after the 72-h incubation period (Table II) . In addition, the increased production of HA by fibroblasts exposed to Additional studies were performed with IL-1 to assess its effect on production of other cellular and secreted GAGs. Fibroblasts were cultured for 24 h with either column buffer (GGBS) or IL-1 containing column fractions, divided into medium and cell layer portions, and the distribution of [3H]-acetate incorporation into HA, CS, DS, and other radioactive polyanions was determined. In the medium, the level of incorporation into HA induced by a column fraction containing IL-1 was four to five times the level seen with column buffer (P < 0.0005). This effect was also seen in the cell layer (P < 0.05), but was much less pronounced (Table III) . No other class of GAG was stimulated to a significant extent (Table III) . Analysis of GAGs in medium from fibroblasts exposed to crude PHA-MNL supernate yielded a similar result (Table III) . These data are consistent with the results obtained by chemical analysis of GAG disaccharides (Table II) .
Stimulation offibroblast HA production by recombinant hrIL-Ja and 3. Results presented thus far strongly suggest that IL-I could stimulate HA synthesis by fibroblasts in culture. To obtain more definitive proof that this was true, and to further characterize this response to IL-1, we performed additional experiments with hrIL-1 a and (. Both hrIL-I s stimulated HA production in a dose-dependent manner (Fig. 3) and at concentrations that triggered murine thymocyte proliferation (Fig.   4 ). We observed that hrIL-1 a and # were usually of similar potency with respect to stimulation of HA production as illustrated in Fig. 3 . However, when we examined 12 consecutive concentrations to cultures of the same fibroblasts for measurement of HA production and to cultures of murine thymocytes to determine their mitogenic effects as described in Methods. Standard errors were < 20% of the mean value. PBS control for fibroblast HA production and thymocyte proliferation were 286±18 and 390±24 cpm, respectively. fibroblast lines, we found that two lines produced more HA in response to hrIL-1 a and one line produced more HA in response to hrIL-l1,, with the remaining lines responding similarly to either IL-1 preparation (data not shown).
Natural and recombinant IL-1 preparations have been shown to stimulate growth of subconfluent fibroblasts in vitro (24) (25) (26) (27) (28) . Although confluent fibroblasts were used in studies to measure HA production, we wanted to exclude the possibility that the recombinant IL-1 preparations were merely increasing HA production by expanding the numbers of fibroblasts per well. Neither IL-1 preparations stimulated growth of confluent fibroblasts under the conditions of the assay (data not shown). These data provide definitive proof that both IL-1 a and ( stimulate fibroblast HA production.
Effect of inhibition ofPGE2 and protein synthesis on IL-Iinduced HA production. Studies with natural and recombinant IL-1 have shown that it stimulates production of PGE2 by human fibroblasts and adherent rheumatoid synovial cells (24, 25, (28) (29) (30) . To determine whether stimulation of PGE2 synthesis by IL-1 was linked to its stimulation of HA production, we measured HA production in IL-1-treated cultures in the presence and absence of indomethacin. Both hrIL-1 a and 1 stimulated PGE2 and HA production (Table IV) . Addition of indomethacin to fibroblast cultures completely blocked the increased PGE2 production induced by the IL-ls. Indomethacin also lowered basal as well as post-IL-1 treatment levels of HA, but it did not alter the magnitude of stimulation of HA production by hrIL-1 a and ( (Table IV) . In five additional experiments in which PGE2 was completely inhibited by indomethacin, piroxicam, or ibuprofen, we also observed no inhibition of IL-1 stimulation of HA production by fibroblasts (data not shown). These results suggest that products of the cyclooxygenase pathway of arachidonic acid metabolism are not involved in the mechanisms by which IL-1 stimulates HA production.
In an effort to determine whether protein synthesis was essential for IL-1 to exert its effect, in two separate experiments we cultured fibroblasts with cycloheximide (7.5 ,ug/ml) and measured HA production in response to IL-1 treatment. In both studies, cycloheximide completely blocked the effect of ,g for its ability to stimu- 50: late production of HA 0°Z
and PGE2by asinglefi-'0 broblast line. Confluent fibroblasts in multiwell plates were placed in maintenance medium (2.5% FCS) with or without the peptide for 24 h and HA and PGE2 were quantitated in triplicate wells as described in Methods. Standard errors were <20% of each mean value.
IL-1 on HA production, suggesting that active protein synthesis was required (data not shown).
Effect ofIL-I (3 peptide 163-171 on fibroblast HA and PGE2 production. Recently, it has been reported that a short synthetic fragment of human IL-1(3 containing residues 163-171 (Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys) stimulated murine thymocyte proliferation but did not stimulate fibroblast PGE2 production or induce fever in mice (31) . We synthesized this peptide and tested its effect in the same experiment on fibroblast HA and PGE2 production. The peptide could induce HA but not PGE2 production (Fig. 5) . The dose-response curve for HA production was bell-shaped with optimal stimulation of HA production occurring with peptide concentrations between 0.6 and 1.2 ,gg/ml (Fig. 5) . Similar bell-shaped dose-response curves were obtained on the two occasions this experiment was repeated with two different fibroblast lines (data not shown). Fibroblast numbers were not significantly different in control and peptide-treated cultures (data not shown). In addition, we have not been able to induce proliferation of subconfluent fibroblasts with this peptide (data not shown). As an additional control, we found an unrelated but similarly charged decapeptide (Leu-Ala-Glu-Leu-Tyr-Val-Arg-Glu-HisLeu) was not able to stimulate HA production by fibroblasts (data not shown).
Antoni et al. found that higher concentrations (175 pg/ml or greater) of this peptide were required to stimulate murine thymocyte proliferation (31) . Assuming a maximal response by IL-I(3 peptide 143-171 in stimulating HA production at 1 , u g / m l and of hrIL-1(3 at 0.2 ng/ml, the peptide is 2,000-fold less potent on a weight basis and 100,000 less potent on a molar basis than recombinant IL-1(.
Discussion
Natural human IL-1(3, hrIL-I a and (3 were found to be potent stimulators of HA production. Synthetic human IL-1(3 peptide 163-171 also stimulates fibroblast HA production but had no effect on PGE2 synthesis. HA is the major species of GAG synthesized by dermal fibroblasts in vitro, and IL-I was found to increase its production to a greater extent than other GAGs.
Active protein synthesis is required for IL-I to exert this effect, but PGE2 does not appear to play a significant role in IL-I stimulation of HA production by fibroblasts.
Whiteside et al. have previously reported that 50,000-and 15,000-D factors from gel filtration of supernatants from human MNL stimulated with concanavalin A increased GAG production by fibroblasts and stimulated murine thymocyte proliferation (32) . These investigators obtained conflicting results with human and rabbit IL-I with regards to stimulation of GAG production by fibroblasts in that a highly purified commercial preparation of human IL-l did not stimulate GAG production under conditions employed in their study, while a partially purified preparation of rabbit IL-1 did stimulate GAG production (32) .
Hamerman and Wood previously reported that a partially purified preparation of human IL-1 from monocytes and synovial cell cultures stimulated synovial cells to synthesize increased quantities of HA but not of sulfated GAGs (33) . Synovial cells used in their study were from arthritic patients undergoing total joint replacement (33) . Such synovial cell cultures are composed of a heterogeneous population of fibroblast-and macrophage-like cells that are morphologically and metabolically very different from dermal fibroblasts (34) (35) (36) . In studies using synovial cells, it is often difficult to directly attribute a given effect to a particular mediator since cell-cell interactions involving release of other mediators are likely to occur. Yaron et al. recently reported that hrIL-l(3 also stimulated adherent rheumatoid synovial cells to produce increased quantities of GAGs (37) . The species of GAGs were not well characterized, and hrIL-1 a effects on synovial cell GAGs were not assessed in that study (37 (47, 48) . In this regard, exogenously added HA has been shown to inhibit mitogen-induced proliferation of lymphocytes, lymphocyte cytotoxicity, and graft-vs.-host reactions (47, 48 
